Skip to main content
Log in

Controverse

Debate

  • Published:
Côlon & Rectum

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Références

  1. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–74

    Article  CAS  PubMed  Google Scholar 

  2. Iversen LH, Rasmussen PC, Laurberg S (2013) Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–92

    Article  CAS  PubMed  Google Scholar 

  3. Passot G, Bakrin N, Isaac S, et al (2014) Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol 40:957–62

    Article  CAS  PubMed  Google Scholar 

  4. Sommariva A, Zagonel V, Rossi CR (2012) The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 19:3737–44

    Article  PubMed  Google Scholar 

  5. Allard MA, Adam R, Ruiz A, et al (2013) Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol 39:981–7

    Article  CAS  PubMed  Google Scholar 

  6. Maggiori L, Goere D, Viana B, et al (2013) Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg 258:116–21

    Article  PubMed  Google Scholar 

  7. Honore C, Goere D, Souadka A, et al (2013) Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review. Ann Surg Oncol 20:183–92

    Article  PubMed  Google Scholar 

  8. Verwaal VJ, Bruin S, Boot H, et al (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–32

    Article  PubMed  Google Scholar 

  9. Verwaal VJ, van Ruth S, de Bree E, et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–43

    Article  PubMed  Google Scholar 

  10. Elias D, Lefevre JH, Chevalier J, et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–5

    Article  PubMed  Google Scholar 

  11. Desolneux G, Maziere C, Vara J, et al (2015) Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only. PloS One 10:e0122816

    Article  PubMed Central  PubMed  Google Scholar 

  12. Matsuda K, Hotta T, Takifuji K, et al (2012) Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis. Surgery 151:238–44

    Article  PubMed  Google Scholar 

  13. Goere D, Malka D, Tzanis D, et al (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257:1065–71

    Article  PubMed  Google Scholar 

  14. Faron M, Macovei R, Goere D, et al (2015) Linear relationship of Peritoneal Cancer Index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol [Epub ahead of print]

    Google Scholar 

  15. Glehen O, Gilly FN, Boutitie F, et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608–18

    Article  PubMed  Google Scholar 

  16. Elias D, Gilly F, Boutitie F, et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric french study. J Clin Oncol 28:63–8

    Article  PubMed  Google Scholar 

  17. Elias D, Honore C, Dumont F, et al (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 254:289–93

    Article  CAS  PubMed  Google Scholar 

  18. Hompes D, Aalbers A, Boot H, et al (2014) A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer. Colorectal Dis 16:264–72

    Article  Google Scholar 

  19. Klaver YL, Lemmens VE, Creemers GJ, et al (2011) Populationbased survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol 22:2250–6

    Article  CAS  PubMed  Google Scholar 

  20. Klaver YL, Simkens LH, Lemmens VE, et al (2012) Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol 38:617–23

    Article  CAS  PubMed  Google Scholar 

  21. Passot G, You B, Boschetti G, et al (2014) Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Ann Surg Oncol 21:2608–14

    Article  PubMed  Google Scholar 

  22. Maillet M GO, Lambert, Goere D, et al Early post-operative chemotherapy after complete cytoreduction and hyperthermic intra peritoneal chemotherapy for isolated peritoneal carcinomatosis of colon cancer: a multicenter study. underreview Journée nationale des carcinoses péritonéales, Paris 2015

    Google Scholar 

  23. Klaver YL, de Hingh IH, Boot H, et al (2011) Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy. J Surg Oncol 103:431–4

    Article  PubMed  Google Scholar 

  24. Passot G, Vaudoyer D, Cotte E, et al (2012) Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Ann Surg 256:125–9

    Article  PubMed  Google Scholar 

  25. Spiliotis J, Efstathiou E, Halkia E, et al (2012) The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome. Hepatogastroenterology 59:705–8

    PubMed  Google Scholar 

  26. Sugarbaker PH (1996) Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Cancer Treat Res 82:79–100

    Article  CAS  PubMed  Google Scholar 

  27. Goere D, Allard MA, Honoré C, et al (2013) Incidence and prognosis of synchronous colorectal carcinomatosis. Fut Oncol 9:541–9

    Article  CAS  Google Scholar 

  28. Segelman J, Granath F, Holm T, et al (2012) Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 99:699–705

    Article  CAS  PubMed  Google Scholar 

  29. Jayne DG, Fook S, Loi C, et al (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545–50

    Article  CAS  PubMed  Google Scholar 

  30. Verwaal VJ, Bruin S, Boot H, et al (2008) 8-Year Follow-up of Randomized Trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–32

    Article  PubMed  Google Scholar 

  31. Elias D, Lefèvre JH, Chevalier J, et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–5

    Article  PubMed  Google Scholar 

  32. Elias D, Goere D, Blot F, et al (2007) Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 °C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 14:1818–24

    Article  PubMed  Google Scholar 

  33. Honoré C, Goere D, Souadka A, et al (2012) Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review. Ann Surg Oncol 20:183–92

    Article  PubMed  Google Scholar 

  34. Elias D, Goere D, Di Pietrantonio D, et al (2008) Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 247:445–50

    Article  PubMed  Google Scholar 

  35. Elias D, Honore C, Dumont F, et al (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 254:289–93

    Article  CAS  PubMed  Google Scholar 

  36. Matsuda K, Hotta T, Takifuji K, et al (2012) Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis. Surgery 151:238–44

    Article  PubMed  Google Scholar 

  37. Mulsow J, Merkel S, Agaimy A, et al (2011) Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases. Br J Surg 98:1785–91

    Article  CAS  PubMed  Google Scholar 

  38. Glehen O, Gilly FN, Boutitie F, et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Cancer 116:5608–18

    Article  PubMed  Google Scholar 

  39. Pestieau SR, Sugarbaker PH (2000) Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum 43:1341–6; discussion 1347–8

    Article  CAS  PubMed  Google Scholar 

  40. Glehen O (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–92

    Article  CAS  PubMed  Google Scholar 

  41. Braam HJ, Boerma D, Wiezer MJ, et al (2013) Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment. Eur J Surg Oncol 39:988–93

    Article  CAS  PubMed  Google Scholar 

  42. Allard MA, Adam R, Ruiz A, et al (2013) Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol 39:981–7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to O. Glehen or J. Lefèvre.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Passot, G., Glehen, O., Sourrouille, I. et al. Controverse. Colon Rectum 9, 230–234 (2015). https://doi.org/10.1007/s11725-015-0601-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11725-015-0601-7

Navigation